Surekha Surendranathan
University of Tennessee Health Science Center(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, SARS-CoV-2 and COVID-19 Research, Click Chemistry and Applications, Antimicrobial Peptides and Activities, Peptidase Inhibition and Analysis
Most-Cited Works
- → Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease(2022)122 cited
- → Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2(2023)89 cited
- → Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19(2020)59 cited
- → Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study(2021)37 cited
- → AI-Accelerated Design of Targeted Covalent Inhibitors for SARS-CoV-2(2023)24 cited
- → Potent and Selective Covalent Inhibitors of the Papain-like Protease from SARS-CoV-2(2021)13 cited
- → Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease: room-temperature X-ray and neutron crystallography, binding thermodynamics, and antiviral activity(2022)5 cited